INmune Bio Inc., headquartered in La Jolla, California, is a clinical-stage immunotherapy company dedicated to reprogramming the innate immune system to combat diverse diseases, including cancer, Alzheimer's disease, and nonalcoholic steatohepatitis. With a robust pipeline of innovative therapies, INmune Bio is positioned at the forefront of the immunotherapy landscape, aiming to harness the body’s natural defenses to improve treatment outcomes. The company's focused approach in addressing significant unmet medical needs underlines its commitment to advancing healthcare and enhancing patient quality of life.